348 related articles for article (PubMed ID: 23801866)
21. Quantitative perfusion analysis in pancreatic contrast enhanced ultrasound (DCE-US): a promising tool for the differentiation between autoimmune pancreatitis and pancreatic cancer.
Vitali F; Pfeifer L; Janson C; Goertz RS; Neurath MF; Strobel D; Wildner D
Z Gastroenterol; 2015 Oct; 53(10):1175-81. PubMed ID: 26480053
[TBL] [Abstract][Full Text] [Related]
22. Meta-analysis of CT and MRI for differentiation of autoimmune pancreatitis from pancreatic adenocarcinoma.
Ha J; Choi SH; Byun JH; Kim KW; Kim SY; Kim JH; Kim HJ
Eur Radiol; 2021 May; 31(5):3427-3438. PubMed ID: 33146798
[TBL] [Abstract][Full Text] [Related]
23. Pancreatic duct abnormalities in focal autoimmune pancreatitis: MR/MRCP imaging findings.
Negrelli R; Manfredi R; Pedrinolla B; Boninsegna E; Ventriglia A; Mehrabi S; Frulloni L; Pozzi Mucelli R
Eur Radiol; 2015 Feb; 25(2):359-67. PubMed ID: 25106489
[TBL] [Abstract][Full Text] [Related]
24. Multimodel magnetic resonance imaging of mass-forming autoimmune pancreatitis: differential diagnosis with pancreatic ductal adenocarcinoma.
Jia H; Li J; Huang W; Lin G
BMC Med Imaging; 2021 Oct; 21(1):149. PubMed ID: 34654379
[TBL] [Abstract][Full Text] [Related]
25. Mass-forming autoimmune pancreatitis and pancreatic carcinoma: differential diagnosis on the basis of computed tomography and magnetic resonance cholangiopancreatography, and diffusion-weighted imaging findings.
Muhi A; Ichikawa T; Motosugi U; Sou H; Sano K; Tsukamoto T; Fatima Z; Araki T
J Magn Reson Imaging; 2012 Apr; 35(4):827-36. PubMed ID: 22069025
[TBL] [Abstract][Full Text] [Related]
26. CT findings in autoimmune pancreatitis: assessment using multiphase contrast-enhanced multisection CT.
Suzuki K; Itoh S; Nagasaka T; Ogawa H; Ota T; Naganawa S
Clin Radiol; 2010 Sep; 65(9):735-43. PubMed ID: 20696301
[TBL] [Abstract][Full Text] [Related]
27. Morphologic patterns of autoimmune pancreatitis in CT and MRI.
Rehnitz C; Klauss M; Singer R; Ehehalt R; Werner J; Büchler MW; Kauczor HU; Grenacher L
Pancreatology; 2011; 11(2):240-51. PubMed ID: 21625195
[TBL] [Abstract][Full Text] [Related]
28. [Imaging features of autoimmune pancreatitis].
Cong GN; Qin MW; You H; Liu W; Xu K
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):479-84. PubMed ID: 18795625
[TBL] [Abstract][Full Text] [Related]
29. Clinical and imaging features of autoimmune pancreatitis with focal pancreatic swelling or mass formation: comparison with so-called tumor-forming pancreatitis and pancreatic carcinoma.
Wakabayashi T; Kawaura Y; Satomura Y; Watanabe H; Motoo Y; Okai T; Sawabu N
Am J Gastroenterol; 2003 Dec; 98(12):2679-87. PubMed ID: 14687817
[TBL] [Abstract][Full Text] [Related]
30. Differential diagnosis of sclerosing cholangitis with autoimmune pancreatitis and periductal infiltrating cancer in the common bile duct at dynamic CT, endoscopic retrograde cholangiography and MR cholangiography.
Kim JH; Byun JH; Lee SJ; Park SH; Kim HJ; Lee SS; Kim MH; Kim J; Lee MG
Eur Radiol; 2012 Nov; 22(11):2502-13. PubMed ID: 22661056
[TBL] [Abstract][Full Text] [Related]
31. Localized Autoimmune Pancreatitis: Report of a Case Clinically Mimicking Pancreatic Cancer and a Literature Review.
Cao Z; Tian R; Zhang T; Zhao Y
Medicine (Baltimore); 2015 Oct; 94(42):e1656. PubMed ID: 26496272
[TBL] [Abstract][Full Text] [Related]
32. Dual-phase CT of autoimmune pancreatitis: a multireader study.
Takahashi N; Fletcher JG; Fidler JL; Hough DM; Kawashima A; Chari ST
AJR Am J Roentgenol; 2008 Feb; 190(2):280-6. PubMed ID: 18212210
[TBL] [Abstract][Full Text] [Related]
33. Systematic review and meta-analysis of MRI features for differentiating autoimmune pancreatitis from pancreatic adenocarcinoma.
Yoon SB; Jeon TY; Moon SH; Lee SM; Kim MH
Eur Radiol; 2022 Oct; 32(10):6691-6701. PubMed ID: 35486167
[TBL] [Abstract][Full Text] [Related]
34. Autoimmune chronic pancreatitis.
Lin LF; Huang PT; Ho KS; Tung JN
J Chin Med Assoc; 2008 Jan; 71(1):14-22. PubMed ID: 18218555
[TBL] [Abstract][Full Text] [Related]
35. Differentiating focal autoimmune pancreatitis and pancreatic ductal adenocarcinoma: contrast-enhanced MRI with special emphasis on the arterial phase.
Kwon JH; Kim JH; Kim SY; Byun JH; Kim HJ; Lee MG; Lee SS
Eur Radiol; 2019 Nov; 29(11):5763-5771. PubMed ID: 31028441
[TBL] [Abstract][Full Text] [Related]
36. A focal mass-forming autoimmune pancreatitis mimicking pancreatic cancer with obstruction of the main pancreatic duct.
Matsumoto I; Shinzeki M; Toyama H; Asari S; Goto T; Yamada I; Ajiki T; Fukumoto T; Ku Y
J Gastrointest Surg; 2011 Dec; 15(12):2296-8. PubMed ID: 21584824
[TBL] [Abstract][Full Text] [Related]
37. Differentiating Mass-Forming Autoimmune Pancreatitis From Pancreatic Ductal Adenocarcinoma on the Basis of Contrast-Enhanced MRI and DWI Findings.
Choi SY; Kim SH; Kang TW; Song KD; Park HJ; Choi YH
AJR Am J Roentgenol; 2016 Feb; 206(2):291-300. PubMed ID: 26797355
[TBL] [Abstract][Full Text] [Related]
38. Sclerosing cholangitis with autoimmune pancreatitis versus primary sclerosing cholangitis: comparison on endoscopic retrograde cholangiography, MR cholangiography, CT, and MRI.
Kim JH; Byun JH; Kim SY; Lee SS; Kim HJ; Kim MH; Lee MG
Acta Radiol; 2013 Jul; 54(6):601-7. PubMed ID: 23528564
[TBL] [Abstract][Full Text] [Related]
39. Strategy to differentiate autoimmune pancreatitis from pancreas cancer.
Takuma K; Kamisawa T; Gopalakrishna R; Hara S; Tabata T; Inaba Y; Egawa N; Igarashi Y
World J Gastroenterol; 2012 Mar; 18(10):1015-20. PubMed ID: 22416175
[TBL] [Abstract][Full Text] [Related]
40. Clinical Utility of FDG PET/CT in Patients with Autoimmune Pancreatitis: a Case-Control Study.
Cheng MF; Guo YL; Yen RF; Chen YC; Ko CL; Tien YW; Liao WC; Liu CJ; Wu YW; Wang HP
Sci Rep; 2018 Feb; 8(1):3651. PubMed ID: 29483544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
